HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alexander Disease.

Abstract
Alexander disease is a leukodystrophy caused by dominant missense mutations in the gene encoding the glial fibrillary acidic protein. Individuals with this disorder often present with a typical neuroradiologic pattern including white matter abnormalities with brainstem involvement, selective contrast enhancement, and structural changes to the basal ganglia/thalamus. In rare cases, focal lesions have been seen and cause concern for primary malignancies. Here the authors present an infant initially diagnosed with a chiasmatic astrocytoma that was later identified as having glial fibrillary acidic protein mutation-confirmed Alexander disease. Pathologic and radiologic considerations that were helpful in arriving at the correct diagnosis are discussed.
AuthorsAli Tavasoli, Thais Armangue, Cheng-Ying Ho, Matthew Whitehead, Miriam Bornhorst, Jullie Rhee, Eugene I Hwang, Elizabeth M Wells, Roger Packer, Marjo S van der Knaap, Marianna Bugiani, Adeline Vanderver
JournalJournal of child neurology (J Child Neurol) Vol. 32 Issue 2 Pg. 184-187 (02 2017) ISSN: 1708-8283 [Electronic] United States
PMID28112050 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Glial Fibrillary Acidic Protein
Topics
  • Alexander Disease (diagnosis, drug therapy, genetics, pathology)
  • Brain (diagnostic imaging, pathology)
  • Brain Neoplasms (diagnosis)
  • Diagnosis, Differential
  • Glial Fibrillary Acidic Protein (genetics)
  • Humans
  • Infant
  • Male

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: